<DOC>
	<DOCNO>NCT02325973</DOCNO>
	<brief_summary>The purpose study ass whether Index Microcirculatory Resistance ( IMR ) consider prognostic predictor occurrence event one year follow primary Percutaneous Coronary Intervention ( PCI ) ST-Elevation Myocardial Infarction ( STEMI ) patient . Any correlation IMR short medium term outcome , define cardiovascular death , re-Myocardial Infarct ( MI ) , re-hospitalization Heart Failure ( HF ) , resuscitation Implantable Cardioverter Defibrillator ( ICD ) appropriate shock , assess study .</brief_summary>
	<brief_title>Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome STEMI Patients Undergoing Primary PCI</brief_title>
	<detailed_description>Prospective , multicentre study design evaluate IMR ability predict event occurrence , define Cardiovascular death , re-MI , re-hospitalization HF , resuscitation ICD appropriate shock , 1 year follow-up period . All participant culprit lesion treat follow clinical practice guideline ; Fractional Flow Reserve ( FFR ) IMR measure primary PCI procedure evaluate treatment success myocardial viability . Non-culprit lesion functionally evaluate FFR index treat FFR show functional stenosis . FFR IMR measure evaluate treatment success myocardial viability . Patients followed-up 1m , 6m 1y period .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient legal age host country able willing provide inform consent form 2 . Hospital admission either within 12 h symptom onset 12 24 h onset evidence continue ischemia 3 . Electrocardiographic STsegment elevation â‰¥1 mm two contiguous ECG lead , leave bundlebranch block ( LBBB ) 4 . Multivessel diseased patient lesion proximal 2/3 part vessel 5 . Culprit Lesion EyeBall ( EB ) identify evaluation basal angiography 6 . Presence least one nonculprit lesion &gt; 50 % EB detect basal angiography eligible PCI operator decision perform stag predischarge angioplasty procedure 1 . Patients give inform consent 2 . A life expectancy le 1 year 3 . Patients pregnant nursing 4 . Contraindication angiography 5 . Allergy/intolerance Adenosine 6 . Contraindication/Allergy/Intolerance contrast medium medical therapy foreseen PCI 7 . Documented allergy Adenosine diphosphate ( ADP ) inhibitor ( aspirin clopidogrel ) 8 . New infarct area previous infarct 9 . Critical non treatable Lesion EB &gt; 70 % downstream culprit lesion 10 . Absence nonculprit lesion/s 11 . Patient hemodynamic instability controllable medical therapy and/or need intra aortic balloon pump implantation ( IABP ) 12 . Prior Coronary Artery Bypass Graft ( CABG ) indication CABG 13 . Patients Left Main ( LM ) coronary artery disease require revascularization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>STEMI</keyword>
	<keyword>IMR</keyword>
	<keyword>FFR</keyword>
	<keyword>microcirculatory</keyword>
</DOC>